04:52 PM EST, 03/05/2025 (MT Newswires) -- Robert I Blum, Director, President & CEO, on March 05, 2025, sold 25,000 shares in Cytokinetics ( CYTK ) for $1,080,750. Following the Form 4 filing with the SEC, Blum has control over a total of 385,317 common shares of the company, with 381,151 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760225008331/xslF345X05/form4.xml